Viewing Study NCT06222593


Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2026-05-21 @ 4:07 AM
Study NCT ID: NCT06222593
Status: RECRUITING
Last Update Posted: 2025-02-17
First Post: 2022-11-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination with Sunitinib in Patients with TKIs-resistant RCC
Sponsor: State University of New York at Buffalo
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Renal Cell View
Keywords: